AstraZeneca invests £1.5bn into US firm Summit for cancer drug tie-up
Each group will retain development and commercial rights to their respective medicines under the agreement, they said (Peter…
#EuropeSays #Britain #Europe #EU #AstraZeneca #cancercells #cancertreatment #equityinvestment #experimentaldrug #gastrointestinalcancer #pharmaceuticalfirm
https://www.europesays.com/britain/138090/
